62 related articles for article (PubMed ID: 22804458)
1. Evaluation of cyclin-dependent kinase-like 1 expression in breast cancer tissues and its regulation in cancer cell growth.
Tang L; Gao Y; Yan F; Tang J
Cancer Biother Radiopharm; 2012 Aug; 27(6):392-8. PubMed ID: 22804458
[TBL] [Abstract][Full Text] [Related]
2. RNAi-mediated downregulation of CDKL1 inhibits growth and colony-formation ability, promotes apoptosis of human melanoma cells.
Song Z; Lin J; Sun Z; Ni J; Sha Y
J Dermatol Sci; 2015 Jul; 79(1):57-63. PubMed ID: 25920913
[TBL] [Abstract][Full Text] [Related]
3. A role for Cdkl1 in the development of gastric cancer.
Sun W; Yao L; Jiang B; Shao H; Zhao Y; Wang Q
Acta Oncol; 2012 Jul; 51(6):790-6. PubMed ID: 22369697
[TBL] [Abstract][Full Text] [Related]
4. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
[TBL] [Abstract][Full Text] [Related]
5. CDKL1 promotes tumor proliferation and invasion in colorectal cancer.
Qin C; Ren L; Ji M; Lv S; Wei Y; Zhu D; Lin Q; Xu P; Chang W; Xu J
Onco Targets Ther; 2017; 10():1613-1624. PubMed ID: 28352193
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of CDKL1 suppresses neuroblastoma cell proliferation, migration and invasion.
Li W; Cao J; Liu J; Chu W; Zhang C; Chen S; Kang Z
Cell Mol Biol Lett; 2019; 24():19. PubMed ID: 30891073
[TBL] [Abstract][Full Text] [Related]
7. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
8. [Effect of silencing hypoxia-inducible factor-1 alpha by RNA interference on human breast carcinoma cell line].
Wang H; Liu YJ; Han ZB; Liang LH; Lv LL; Han ZC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):670-4. PubMed ID: 17121229
[TBL] [Abstract][Full Text] [Related]
9. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
[TBL] [Abstract][Full Text] [Related]
11. A new indole-3-carbinol tetrameric derivative inhibits cyclin-dependent kinase 6 expression, and induces G1 cell cycle arrest in both estrogen-dependent and estrogen-independent breast cancer cell lines.
Brandi G; Paiardini M; Cervasi B; Fiorucci C; Filippone P; De Marco C; Zaffaroni N; Magnani M
Cancer Res; 2003 Jul; 63(14):4028-36. PubMed ID: 12874002
[TBL] [Abstract][Full Text] [Related]
12. Analysis of cell growth inhibitory effects of catechin through MAPK in human breast cancer cell line T47D.
Deguchi H; Fujii T; Nakagawa S; Koga T; Shirouzu K
Int J Oncol; 2002 Dec; 21(6):1301-5. PubMed ID: 12429981
[TBL] [Abstract][Full Text] [Related]
13. CDKL1 promotes the chemoresistance of human oral squamous cell carcinoma cells to hydroxycamptothecin.
Li K; Meng Z; Jiang L; Xia C; Xu K; Yuan D; Chen H; Zhang B; Liu S
Mol Cell Probes; 2019 Apr; 44():57-62. PubMed ID: 30802495
[TBL] [Abstract][Full Text] [Related]
14. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
16. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
[TBL] [Abstract][Full Text] [Related]
17. Egr‑1 inhibits colon cancer cell proliferation, migration and invasion via regulating CDKL1 at the transcriptional level.
Shao S; Ju M; Lei J; Lu X; Li H; Wang D; Xia C
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34165179
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy.
Pan Q; Bao LW; Kleer CG; Sabel MS; Griffith KA; Teknos TN; Merajver SD
Cancer Res; 2005 Sep; 65(18):8366-71. PubMed ID: 16166314
[TBL] [Abstract][Full Text] [Related]
19. Silencing of human phosphatidylethanolamine-binding protein 4 sensitizes breast cancer cells to tumor necrosis factor-alpha-induced apoptosis and cell growth arrest.
Wang X; Li N; Li H; Liu B; Qiu J; Chen T; Cao X
Clin Cancer Res; 2005 Oct; 11(20):7545-53. PubMed ID: 16243830
[TBL] [Abstract][Full Text] [Related]
20. Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1).
Groshong SD; Owen GI; Grimison B; Schauer IE; Todd MC; Langan TA; Sclafani RA; Lange CA; Horwitz KB
Mol Endocrinol; 1997 Oct; 11(11):1593-607. PubMed ID: 9328342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
